Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Vaccinova AB
AB
Active
Org 5569830002
Bielkegatan 2 C, 582 21
Linköping
General medical practice activities
·
NACE 8621
Est. 2014 · 11 years old
43 employees
Monitor
Share
Sweden
/
Companies
/
General medical practice activities
/
Vaccinova AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
172M
129M
86M
43M
0M
2021: 27M
27M
2021
2022: 38M (+41% vs 2021)
38M
+41%
2022
2023: 69M (+82% vs 2022)
69M
+82%
2023
2024: 89M (+29% vs 2023)
89M
+29%
2024
2025: 138M (+55% vs 2024)
138M
+55%
2025
EBITDA
SEK millions
24M
18M
12M
6M
0M
2021: 1M
1M
2021
2022: 0M (-100% vs 2021)
0M
-100%
2022
2023: 7M
7M
2023
2024: 5M (-29% vs 2023)
5M
-29%
2024
2025: 19M (+280% vs 2024)
19M
+280%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
138 001
89 206
69 166
37 751
27 127
Staff expenses
−31 304
—
—
—
—
EBITDA
18 645
4 651
7 323
−408
746
Depreciation & amort.
−372
−328
−249
−158
−96
EBIT
18 273
4 323
7 074
−566
650
Net financials
155
62
23
−24
−12
Profit before tax
18 502
4 373
6 996
36
639
Tax
−3 859
−931
−1 468
−35
−152
Net profit
14 642
3 442
5 528
1
487
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
36 606
14 134
13 852
5 838
4 878
Equity
15 254
5 612
7 170
1 642
1 641
Long-term debt
—
0
0
0
0
Short-term debt
21 231
8 328
6 501
4 116
2 533
Total debt
21 231
8 328
6 501
4 116
2 533
Financial ratios
5-year trend
EBITDA margin
13,5 %
This company
15,8 %
Market median
This company
Market median
15% below market
2021
2025
Equity ratio
41,7 %
This company
38,2 %
Market median
This company
Market median
9% above market
2021
2025
Return on equity
96,0 %
This company
18,4 %
Market median
This company
Market median
422% above market
2021
2025
Net profit margin
10,6 %
This company
8,1 %
Market median
This company
Market median
31% above market
2021
2025
Asset turnover
3,77×
This company
1,12×
Market median
This company
Market median
237% above market
2021
2025
Debt / equity
1,40×
This company
0,62×
Market median
This company
Market median
126% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Vaccinova AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
